Friday, May 16, 2014

Top 5 Dow Dividend Companies For 2015

Here's a depressing piece of news if you're a shareholder of�Bank of America (NYSE: BAC  ) : Over the last four months, analysts have reduced their first-quarter earnings-per-share targets for the Charlotte-based bank by a whopping 83%, going from $0.30 per share at the beginning of the year down to $0.05 per share today.

According to The Wall Street Journal, estimates related to the majority of the nation's largest lenders started being slashed in February "amid mounting evidence that bank traders found fewer opportunities to make money in debt and currency markets and bond underwriting slumped."

"The easy money has been made on U.S. banks," a person at Manulife Asset Management told the Journal.

Company

Consensus Estimate (January 1)

Consensus Estimate (April 3)

Top 5 Dow Dividend Companies For 2015: Encore Capital Group Inc(ECPG)

Encore Capital Group, Inc., through its subsidiaries, engages in consumer debt buying and recovery business primarily in the United States. The company purchases and manages portfolios of defaulted consumer receivables, such as consumers? unpaid financial commitments to credit originators, including banks, credit unions, consumer finance companies, commercial retailers, auto finance companies, and telecommunication companies; and receivables subject to bankruptcy proceedings or consumer bankruptcy receivables. It also provides bankruptcy services to the finance industry, such as negotiating bankruptcy plans, monitoring and managing consumer?s compliance with bankruptcy plans, and recommending courses of action to clients in case of a deviation from a bankruptcy plan. The company was founded in 1998 and is headquartered in San Diego, California.

Advisors' Opinion:
  • [By John Udovich]

    Small cap debt collection stocks like�Asta Funding, Inc (NASDAQ: ASFI), Encore Capital Group, Inc (NASDAQ: ECPG) and Portfolio Recovery Associates, Inc (NASDAQ: PRAA) could be the latest target of a government shakedown or crackdown as the Consumer Financial Protection Bureau said this week that�before it formally proposes any rules for debt collection, it wants to hear how collectors verify borrowers' information and communicate with consumers. In other words, debt collectors could be restricted from using text messages, social media or other Internet-based tools in their pursuit to collect debts. With about one in 10 Americans coming out of the financial crisis with some debt in collection, investing in small cap�debt collection stocks has been profitable for investors. However, there is no timeline for when any new rules might be released for review or come into effect.

  • [By Lawrence Meyers]

    The other good news is on pages 10, 11 and 15. Delinquencies are rising, as are collections. If debt balances increase, you would expect delinquencies to rise as well. That bodes well for the big-time players in debt collection, Portfolio Recovery Associates (PRAA) and Encore Capital Group (ECPG). Both just reported robust growth in collections, revenues, and net income. They’re also making large international acquisitions. I love both companies and think they’re are undervalued.

  • [By Sally Jones]

    Today�� diverse companies were chosen for their speculative enterprises. Both companies deal in the territory of what if. If Encore Capital Group Inc. (ECPG) can collect more from a huge portfolio of consumer debt, the company would grow. If Sophiris Bio Inc. (SPHS), a 10-person biopharm, is successful in competing to provide relief for prostate BPH symptoms, the company would soar.

Top 5 Dow Dividend Companies For 2015: HomeAway Inc (AWAY)

HomeAway, Inc. (HomeAway), incorporated on April 6, 2004, is an online marketplace for the vacation rental industry. As of December 31, 2012, the Company operated its online marketplace through 44 websites in 13 languages. During the year December 31, 2012, the Company had over 600 million Website visits. As of December 31, 2012, its global marketplace included more than 710,000 paid listings of vacation rentals. HomeAway portfolio includes the vacation rental Websites: HomeAway.com, VRBO.com and VacationRentals.com in the United States; HomeAway.co.uk and OwnersDirect.co.uk in the United Kingdom; HomeAway.de in Germany; Abritel.fr and Homelidays.com in France; HomeAway.es in Spain; AlugueTemporada.com.br in Brazil, and HomeAway.com.au in Australia. In April 2012, the Company acquired 100% of the outstanding stock of Top Rural S.L. In November 2013, the Company announced that it has secured a 55% interest of Bookabach Limited, the operator of a vacation rental site in New Zealand.

HomeAway operates BedandBreakfast.com, a global site for finding bed and breakfast properties, providing travelers with another source for lodging alternatives to hotels, and HomeAway Software for Professionals at software.HomeAway.com, to offer software solutions to property managers and innkeepers. Its online marketplace serves two major constituents: property owners and managers on one side and travelers on the other. Property owners and managers pay listing fees, which are annual subscriptions, to provide detailed listings of their properties on its Websites and reach an audience of travelers seeking vacation rentals. Travelers visit its marketplace at no charge and are able to search and compare its large and detailed inventory of paid listings to find vacation rentals meeting their requirements.

Products and Services for Property Owners and Managers

Paid listings are purchased in advance by property owners or managers as a form of advertising to promote their vacation rentals to ! prospective travelers on one or more of its Websites, typically for one year. Paid listings appear in search results on its websites when travelers search for vacation rentals based on traveler search criteria. During the year ended December 31, 2012, paid listings accounted for 84.9% of the Company�� revenue. ReservationManager includes tools and services to help property owners and managers run their vacation rental businesses more efficiently. ReservationManager enables property owners and managers to respond to and manage inquiries, prepare and send rental quotes and payment invoices, allow travelers to book online, including being able to enter into rental agreements with travelers online, and process online payments via Visa, MasterCard, Discover or eCheck. Additionally, through ReservationManager, property owners and managers can provide value-added products to travelers for purchase such as property damage protection.

Property owners and managers may purchase additional enhancements to their listings to increase the marketing exposure of their properties on certain of our websites, such as: Cross-Sell Listings or Bundles and Featured Listings, Special Offers and Deals. Performance-Based Listings property managers can use its enterprise and Web-based software solutions to manage their businesses, customers and properties. The Company provide software solutions to property managers under the brand names HomeAway Software for Professionals, Escapia, PropertyPlus, V12, Entech and First Resort and offer software tailored to professional bed and breakfast innkeepers under the brand names Webervations and Rezovations. Third-Party Services offer property owners and managers several ancillary products and services on selected websites. These products and services include credit card merchant accounts, trip insurance and property damage protection, and tax return services. BedandBreakfast.com Redistribution through its professional software for bed and breakfasts and professional property m! anagers, ! it make selected, online e-bookable properties available to online travel agencies, including Expedia, Travelocity and Priceline, as well as channel partners such as FlipKey.com and PackLate.com. Property Owner and Manager Community provide resources for property owners and managers to seek advice and obtain answers to optimize their business. These resources include a community site, email newsletters, online forums and online seminars.

Products and Services for Travelers

The products and services are offered to travelers at no cost, which include Search and Compare, Traveler Login, Trust and Security, Listing Reviews and Ratings, Traveler Community and Mobile Websites and Applications. Search and compare is an online marketplace provides travelers with tools to search for vacation rentals based on various criteria, such as location, type of property, number of bedrooms, amenities, availability or keywords. Travelers are able to create accounts that enable them to log in to certain of our websites. Travelers can then send inquiries to property owners and managers without having to fill in their information for each inquiry. Trust and security reviews new listings selectively for content, appropriateness, and quality of description. Travelers are invited to submit online reviews of the vacation rentals they have rented through its Websites. These reviews are intended to convey the accuracy of the listing information found on its Websites.

Traveler community who have made at least one inquiry on one of the Company�� Websites are maintained in a database and receive regular communications, including notices about places of interest, special offers, new listings, and an e-mail newsletter. Mobile Websites and applications provides versions of its Websites formatted for Web browsers on smartphones and tablets so that travelers can access its Websites and find and inquire about vacation rentals when they are away from a computer. It also provides applications for tra! velers to! find and inquire about vacation rentals using their smartphones and tablets.

Value-Added Services

The Company�� Value-Added Services includes Carefree Rental Guarantee, Insurance Products and Tax Filing Services. Carefree Rental Guarantee, which is offered at no cost to travelers, it offer a Carefree Rental Guarantee in the United States for a fee, which provides additional financial protection against fraud if the property found on its Website is illegitimate, not as advertised, or not available to the traveler upon check-in, and, as a result, the traveler incurs a financial loss. Insurance Products have contracted with third party insurance providers to offer travelers insurance products for purchase to protect against unexpected events relating to their trips, such as property damage protection, trip cancellation protection, personal liability, medical fees and legal expenses. Tax Filing Services to assist its property owners and managers in complying with applicable tax regulations, it contract with a third party in the United States to provide tax preparation and filing services for its property owners and managers.

Advertising

The Company�� advertising includes Display Advertising and Sponsorships and Site Integrations. Display Advertising sells Internet display advertising on the majority of the Company�� Websites. Advertisers, including those offering complementary products of interest to the visitors to its Websites, are able to purchase advertising positions for a fee based upon the number of impressions and the placement of the advertisement on the page. Sponsorships and site integrations sell sponsorships and site integrations to selected advertisers on its online marketplace. Sponsors purchase a certain number of impressions for a fee, or in the case of site integrations, pay the Company on a cost-per-action basis.

The Company competes with TripAdvisor.com, FlipKey.com, HolidayLettings.co.uk, Wyndam Worldwide Corp., I! nterHome,! AG, Hyatt Vacation Clubs, Four Seasons Resorts, VacationRoost; Expedia, Inc., Hotels.com LP, Kayak Software Corporation, Orbitz, Inc., priceline.com Incorporated, Travelocity.com Inc., Interval International, Inc. and RCI, LLC, Airbnb, Inc., craigslist, Inc., eBay Inc., Google Inc. and Bing.

Advisors' Opinion:
  • [By Mani]

    HomeAway, Inc. (NASDAQ: AWAY) shares could be among the best potential 2014 performers in the mid-cap Internet space as the company rolls out its pay-per-booking (PPB) model, fine- tunes its operations, and then ramps marketing its spend into 2015 to drive growth through the new model.

  • [By Michael Cintolo]

    HomeAway (AWAY)

    It�� not as sexy as some other stories, but we believe HomeAway has all of the characteristics of a big winner��t serves a mass market, it offers a major benefit to consumers, it dominates its market.

  • [By Michael Cintolo]

    HomeAway (AWAY) makes money by helping renters to list, advertise, and manage bookings online, and its innovative pricing strategies allow property owners to pay more for enhanced listings and search options.

5 Best Japanese Stocks To Buy Right Now: Utah Medical Products Inc.(UTMD)

Utah Medical Products, Inc. produces medical devices for the healthcare industry primarily in the United States and Europe. The company provides labor and delivery/obstetrics products, including fetal monitoring accessories, vacuum-assisted delivery systems, and other obstetrical tools, as well as neonatal intensive care products, such as DISPOSA-HOOD, an infant respiratory hood; DELTRAN PLUS, a blood pressure monitoring system; and GESCO, a biocompatible silicone catheter. It also offers umbilical vessel and artery, thermosensitive polyurethane, and peripherally inserted central venous catheters; enteral feeding devices; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; and MYELO-NATE for obtaining cerebral spinal fluid samples. In addition, the company provides gynecology/urology/electrosurgery products comprising LETZ System to excise cervical intraepithelial neoplasia; FINESSE electrosurgical generator; FILTRESSE evacuators ; EPITOME, an electrosurgical scalpel; PATHFINDER PLUS, an endoscopic irrigation device; LIBERTY system to treat and control urinary incontinence in women; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal uterine bleeding; and LUMIN for manipulating the uterus. Further, it offers DELTRAN for blood pressure monitoring; and pressure monitoring accessories, components, and other molded parts. The company?s products are used in neonatal intensive care units, labor and delivery departments, and women?s health center in hospitals, as well as in outpatient clinics and physician's offices. It markets its products through direct sales representatives, independent manufacturers? representatives, specialty distributors, national hospital distribution companies, and other medical device manufacturers; and through other medical device companies and independent medical products distributors. The company was founded in 1978 and is headquar tered in Midvale, Utah.

Advisors' Opinion:
  • [By Geoff Gannon]

    Utah Medical Products (UTMD)

    There are some interesting stories on that list. Buffett watchers know The Washington Post. Ben Graham fans know National Presto. Anyone who follows net-nets is familiar with Micropac. If you��e a high ROC investor you��e probably come across Utah Medical Products (operating margins are over 30%). Atrion has one of the most interesting histories of value creation starting in the 1990s. And Arden is a grocer that earns a 15% return on equity in a bad year.

Top 5 Dow Dividend Companies For 2015: Radian Group Inc.(RDN)

Radian Group Inc., through its subsidiaries, operates as a credit enhancement company in the United States. The company offers credit-related insurance coverage, primarily through private mortgage insurance, and risk management services to mortgage lending institutions. Its private mortgage insurance protects the holders of the company?s insurance from default-related losses on residential mortgage loans made generally to home buyers, as well as facilitates the sale of these mortgage loans in the secondary mortgage market. The company primarily serves mortgage originators, such as mortgage bankers, mortgage brokers, commercial banks, savings institutions, credit unions, and community banks. Radian Group Inc. was founded in 1977 and is headquartered in Philadelphia, Pennsylvania.

Advisors' Opinion:
  • [By James E. Brumley]

    Never let it be said I didn't follow up on my prior ideas and commentaries. In November of last year I said MGIC Investment Corp. (NYSE:MTG), Radian Group Inc. (NYSE:RDN), and Genworth Financial Inc. (NYSE:GNW) were budding bullish idea.

    For those of you with good memories, you'll likely know why that sounds a little bit "off." Though GNW, MTG, and RDN had all three been quite bullish that particular day as well as flashed bursts of bullishness in the days leading up to that November 1st look, the market was still more than a little pessimistic on on insurers like Radian Group, MGIC Investment, and Genworth Financial. I'm sure glad I was willing to go out on a limb. All three stocks have gone on to make big - and surprising - gains.

    So do I come here to pound my chest on RDN, GNW, and MTG? Nope - not at all. I'm chiming in again today to let you know if you got in on my advice, it's now time to lock in those gains and get out.

    Just so there's no confusion, I don't see any particular overbearing problems hanging over the industry's head. It's just that these stocks have outlived their usefulness and opportunity for us.

    Take MGIC Investment Corp. for instance. MTG has advances 340% since then, yet still isn't profitable on a net trailing basis. Positive earnings are sill in the cards. But, priced at 27.6 times 2014's projected income, the value argument is gone, as well as the technical one.

    Ditto for Genworth Financial and Radian Group Inc. Both stocks have posted huge gains over the past ten months, and while their forward-looking ratios are more attractive, after a 118% and 200% runup, respectively - given the back stories and timing - you have to believe the best-case scenario has already been priced into RDN and GNW shares.

    Just for the record, I would be more than willing to buy back into any and all of these names once we get a healthy pullback and start to see decent evidence of a bullish reversal. While we

  • [By Matt Koppenheffer and David Hanson]

    Despite trading lower in the morning, the oft-volatile Radian Group (NYSE: RDN  ) pared losses and climbed into the green. In this video, Motley Fool financial analysts Matt Koppenheffer and David Hanson discuss Radian, as well as two other stocks ticking lower today.

Top 5 Dow Dividend Companies For 2015: Pain Therapeutics Inc (PTIE)

Pain Therapeutics, Inc., incorporated in May 1998, is a biopharmaceutical company that develops drugs. The Company has four drug candidates in clinical programs, including REMOXY, abuse-resistant hydromorphone, abuse-resistant hydrocodone and a radio-labeled monoclonal antibody to treat metastatic melanoma. It is also working on a new treatment for patients with hemophilia. The Company�� lead drug candidate is REMOXY, which is a painkiller. It has collaboration agreement with King Pharmaceuticals, Inc. (King) develops and commercializes REMOXY and other opioid painkillers. The Company and King jointly managed a Phase III clinical program and New Drug Application (NDA) submission for REMOXY. It is also developing a pipeline of drug candidates in the area of oncology and hematology. It owns all commercial rights to its pipeline of drug candidates in oncology and hematology. As of December 31, 2010, the Company leased approximately 30,700 square feet of space in San Mateo, California and all of its operations are located in San Mateo.

REMOXY

REMOXY is a controlled-release oral capsule form of oxycodone in a highly viscous liquid formulation matrix that includes excipients. It is formulated to help address issues of abuse and misuse of time-release oxycodone tablets. REMOXY�� capsule dosage form provides therapeutic drug levels of oxycodone on a twice-daily dosing schedule, while resisting the rapid increases in plasma levels of oxycodone associated with common methods of abuse and misuse. Its formulation also resists delivery by unapproved routes of administration, such as injection, snorting or inhalation.

Metastatic Melanoma

The Company is developing a drug candidate called PTI-188 to treat metastatic melanoma, a form of skin cancer. PTI-188 is a monoclonal antibody linked to a radioisotope, intended to deliver doses of radiation lethal to melanoma tumors without harming normal tissue. In March 2010, the Company announced data from two open-label! , dose-escalating Phase I studies conducted in Israel to assess the safety, pharmacokinetics, dosimetry and anti-tumor activity of PTI-188. During the year ended December 31, 2010, the second study was completed. The technology used in this program was developed at the Albert Einstein College of Medicine (AECOM). It had licensed worldwide commercial rights to this technology from AECOM.

Hemophilia

The Company has a gene transfer program, initially developed at Stanford University, focused at correcting a genetic disorder in which patients are unable to stop bleeding. During 2010, it conducted a variety of pre-clinical studies with this technology. The Company has licensed worldwide commercial rights to the technology used in this program from Poetic Genetics, LLC (Poetic).

Other product candidates

The Company�� alliance with King includes development of three other abuse-resistant opioid product candidates: hydromorphone, hydrocodone and oxymorphone. Its abuse-resistant formulations of hydromorphone and hydrocodone have completed Phase I clinical trials. In January 2011, the Company announced that the Food and Drug Administration (FDA) had accepted its investigational IND, for abuse-resistant oxymorphone.

The Company competes with Roxane Laboratories, Purdue Pharma, King Pharmaceuticals, Inc., Abbott Laboratories, Cephalon, Endo Pharmaceuticals, Teva Pharmaceuticals, Elkins-Sinn, Watson Laboratories, Ortho-McNeil Pharmaceutical and Forest Pharmaceuticals.

Advisors' Opinion:
  • [By Sean Williams]

    However, all isn't well when it comes to the future of abuse-resistant painkiller Remoxy, which was developed by Pain Therapeutics (NASDAQ: PTIE  ) , using Durect's�special technology-based gel capsule to prevent abuse, and is licensed by Pfizer (NYSE: PFE  ) . Remoxy has been rejected twice by the FDA -- the most recent coming in mid-2011 -- and Pfizer commented this morning that if it were to seek reapproval for the drug it wouldn't be for at least two more years. Given Pfizer's extensive product pipeline, losing Remoxy wouldn't be a big deal. For micro-cap clinical-stage companies like Pain Therapeutics and Durect, it'd be a gigantic blow. Fittingly, Pain Therapeutics and Durect shares imploded by 50% and 34%, respectively, on Friday.

  • [By Jessica Alling]

    Elsewhere, Pfizer is evaluating its continued partnership on an experimental oxycodone capsule, Remoxy. The drug is an extended-release formula that is targeted at reducing abuse of the painkiller. After years of setbacks and postponements for FDA approval, Pfizer is weighing its options. Its partners for the drug, Pain Therapeutics (NASDAQ: PTIE  ) and Durect, have both fallen heavily due to the news, with Pain Therapeutics falling more than 50% -- its largest decline ever.

No comments:

Post a Comment